NICE (National Institute for Health and Care Excellence) is a UK-based organization that develops evidence-based guidelines and recommendations for health and social care in England and Wales.
Some European countries also follow NICE guidance as it is considered a reliable and high-quality source of health information.
NICE aims to improve the quality and consistency of care by providing recommendations based on the best available evidence. They also assess new health technologies and medicines to determine their clinical effectiveness and cost-effectiveness.
The NICE menopause guideline, published 2015 and updated in 2024, informs the practice of British Menopause Society registered Menopause Specialists.
Further clinical guidance from the British Menopause Society, Royal College of Obstetricians and Gynaecologists, International Menopause Society and European Society of Human Reproduction and Embryology provides clinical detail.
The patient arm of the British Menopause Society -Women’s Health Concern - publishes and updates patient information factsheets reflecting many aspects of clinical guidance.
Benefits and Risks of HRT
Women’s Health Concern (WHC) is the patient arm of the British Menopause Society (BMS)
and is a trusted resource for information about all aspects of women’s health.
download their information here click here
NICE menopause guideline, updated 2024, published pictogram charts explaining risks of various health conditions – including breast cancer – with and without HRT use – and how risks can alter with age.
Many factors affect our personal risk of breast cancer.
National Institute for Health and care Research (2023) put risks into perspective.
Another reliable source of information is from Women’s Health Concern, download their PDF here